Drug treatment of hyperlipidemia in the elderly: HMG-CoA reductase inhibitors and fibric acid derivatives

被引：0
|
作者：
Zambon, A [1 ]
Baggio, G [1 ]
Crepaldi, G [1 ]
机构：
[1] UNIV WASHINGTON,SEATTLE,WA 98195
来源：
DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS | 1996年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：459 / 464
页数：6
相关论文
共 50 条
  • [31] FIBRATES AND HMG-COA REDUCTASE INHIBITORS
    HUFF, MW
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1991, 145 (08) : 977 - 977
  • [32] HMG-CoA reductase inhibitors and the kidney
    Campese, VA
    Hadaya, B
    Chiu, J
    CURRENT HYPERTENSION REPORTS, 2005, 7 (05) : 337 - 342
  • [33] HMG-CoA reductase inhibitors and the kidney
    Campese, V. M.
    Park, J.
    KIDNEY INTERNATIONAL, 2007, 71 (12) : 1215 - 1222
  • [34] Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors
    Langone, AJ
    Chuang, P
    TRANSPLANTATION, 2006, 81 (05) : 804 - 807
  • [35] BILE-ACID DERIVED HMG-COA REDUCTASE INHIBITORS
    ENHSEN, A
    WESS, G
    HAN, XB
    KRAMER, W
    BOCK, K
    FALK, E
    GLOMBIK, H
    HOFFMANN, A
    MULLNER, S
    NECKERMANN, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 47 - MEDI
  • [36] BILE-ACID DERIVED HMG-COA REDUCTASE INHIBITORS
    KRAMER, W
    WESS, G
    ENHSEN, A
    BOCK, K
    FALK, E
    HOFFMANN, A
    NECKERMANN, G
    GANTZ, D
    SCHULZ, S
    NICKAU, L
    PETZINGER, E
    TURLEY, S
    DIETSCHY, JM
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1227 (03): : 137 - 154
  • [37] Predictive Modeling of HMG-CoA Reductase Inhibitory Activity and Design of New HMG-CoA Reductase Inhibitors
    Samizo, Shigeyoshi
    Kaneko, Hiromasa
    ACS OMEGA, 2023, 8 (30): : 27247 - 27255
  • [38] HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
    Wang, PS
    Solomon, DH
    Mogun, H
    Avorn, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (24): : 3211 - 3216
  • [39] HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis
    Joel D. Mermis
    Steven Q. Simpson
    Current Infectious Disease Reports, 2012, 14 : 484 - 492
  • [40] Safety profiles for the HMG-CoA reductase inhibitors - Treatment and trust
    Davidson, MH
    DRUGS, 2001, 61 (02) : 197 - 206
12345